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specifically to help establish good breast-feeding technique and 
build-up the milk supply, is another possibility,'-!' Referring the 
mother to knowledgeable health workers after discharge is 
important to encourage and help her in breast-feeding the 
infant. Attention to these factors should result in an increase in 
the breast-feeding rate on discharge. 
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THE METABOLIC SYNDROME IN 
BLACK HYPERTENSIVE WOMEN-
WAIST CIRCUMFERENCE MORE 
STRONGLY RELATED THAN BODY 
MASS INDEX 
P Rheeder, R P Stolk, J F Veenhouwer, D E Grobbee 
Objective. To examine the association between measures of 
obesity and features of the metabolic syndrome in treated 
black female hypertensive subjects. 
Design. Cross-sectional study. 
Setting. An urban primary health care centre in Mamelodi, 
Pretoria. 
Subjects. Women with hypertension and without known 
diabetes mellitus or secondary causes of hypertension. In 
total124 women participated, with a mean age of 56.9 years 
(standard deviation (SO) 11.0) and mean body mass index 
(BMI) of 34.1 kg/m' (SO 8.1). 
Main outcome measures. Blood pressure, glucose, insulin and 
lipid levels. 
Results. Waist circumference and waist-hip ratio were more 
strongly associated with insulin, uric acid, glucose and 
triglycerides than was BMI. Statistically significant 
associations were found between waist circumference and 
low high-density lipoprotein HOL cholesterol (standardised 
regression coefficient --0.006, standard error of the mean 
(SEM) 0.002), log triglycerides (0.007, SEM 0.003), uric acid 
(0.002, SEM 0.001) and log insulin (0.012, SEM 0.003). BMI 
was only significantly associated with uric acid (0.002, SEM 
0.002) and log insulin (0.009, SEM 0.004). 
Conclusion. In a group of black hypertensive women 
measures of central obesity were more strongly associated 
with components of the metabolic syndrome than BMI. 
S Afr Med J 2002; 92:637-641. 
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General obesity is a risk factor for cardiovascular disease in 
both men and womenY The excess risk associated with obesity 
is largely mediated by other risk factors such as hypertension, 
hyperlipidaemia and hyperglycaemia. Results from some 
studies, however, have shown obesity to be a risk factor for 
coronary artery disease independently of these factors.'·' 
The abdominal distribution of adiposity appears to be even 
more important than obesity per se for coronary risk. Cross-
sectional analyses have shown that intra-abdominal fat is 
increased in men with signs of coronary heart disease (CHD).' 
Intra-abdominal adiposity also explains the increased risk of 
CHD among South Asians in London.' Central or abdominal 
obesity is linked to insulin resistance and frequently clusters 
with other cardiac risk factors. Called Syndrome X by Reaven 
in 1988,' it is now more often referred to as the metabolic 
syndrome.' This syndrome has been described in various ethnic 
groups such as Europids, AfroAmericans, Asian Indians, 
Australian Aborigines, Polynesians and Micronesians.8·' 
The intercorrelations of obesity, blood pressure (BP) and 
glucose intolerance, hyperinsulinaemia, high plasma 
triglycerides and low high-density lipoprotein (HDL) 
cholesterol in population surveys have led to the idea of a 
common underlying disturbance.w,n It has been proposed that 
resistance to insulin-stimulated glucose uptake is the key to 
this clustering of components." 
Obesity is particularly prevalent in South African black 
women and some urban and rural studies have shown that in 
these subjects obesity does not necessarily accompany 
hypertension, diabetes or hyperlipidaemia."·14 In contrast, 
Omar et a/.15 found that black women with diabetes did have a 
higher body mass index (BMI) than women without diabetes. 
Waist circumference has been shown to predict type 2 diabetes 
mellitus (DM) and to cluster with cardiovascular risk factors in 
subjects of mixed ancestry. 16•17 
Few studies specifically address obesity or insulin resistance 
and the associated cardiovascular risk factors in South African 
black hypertensive patients. 
The aim of this study was to examine the association 
between measures of obesity and other cardiovascular risk 
factors in treated black female hypertensive subjects. 
SUBJECTS AND METHODS 
Mamelodi Hospital was selected .for the study as it serves 
largely as a primary health care facility for the community of 
Mamelodi (approximately 500 000 inhabitants), a stable 
community of lower to middle class inhabitants, north-east of 
Pretoria and now part of the city of Pretoria. The hospital is 
run by the Department of Family Medicine and its main focus 
is on ambulatory medicine. For most patients consulting these 
doctors this is their first contact with the health care system. 
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Few patients are referred from general practitioners in the 
community. There are no laboratory facilities. Specimens are 
sent to Pretoria Academic Hospital for analysis. For this reason 
routine blood tests are seldom done and only if indicated 
clinically. An estimated 3 000 subjects are seen annually at 
Mamelodi Hospital in the outpatient facility with either 
hypertension or diabetes. 
At the outpatient clinic for hypertension women were 
sequentially invited to participate in the study. Patients with 
known DM (defined as a previous fasting blood glucose of 
> 7 mmol/1 or a random value of> 11.1 mmol/1 or using 
glucose-lowering medication) were excluded. There were no 
subjects with known secondary causes of hypertension. Of the 
214 women thus selected, 81 were not proficient in English and 
9 refused to participate. All patients included in this study 
were known hypertensives (N = 124) on drug treatment. 
All clinical measurements were done by a single observer 
(JFV). BP was measured in the sitting position using a 
Baumanometer after at least 5 minutes' rest. Two 
measurements were taken, with at least 1 minute between 
measurements. When there was a difference of more than 5 
mmHg between readings a third reading was taken and the 
mean of the two closest measurements was used to determine 
the mean BP. Mid-arm circumference was measured and a 
large cuff (15 em rubber bladder) was used for an arm 
circumference 35 em or greater. 
Weight was determined to the nearest 0.1 kg, with the 
patient standing barefoot in light clothing on a balance-beam 
scale that was calibrated weekly. Height was determined to the 
nearest 0.1 em using a measuring stick attached to the scale, . 
and for each patient BMI was calculated according to the 
formula weight/height.' Waist-hip ratio (WHR) was 
determined by measuring the waist at the smallest diameter 
between the xyphoid process and the umbilicus (at the end of a 
mild expiration), and the hip at the level of the maximal 
protrusion of the gluteus maximus muscles posteriorly and the 
symphysis pubis anteriorly. Two measurements were taken and 
if there was more than 2 em difference a third was taken. The 
mean of the two measurements or the closest two in the case of 
three measurements was used to calculate the WHR. 
On a separate visit, fasting blood samples were collected 
from a cubital fossa vein. Blood was taken between 07h30 and 
10h00; it was centrifuged within 2 hours and the plasma 
separated. Analyses of urea and electrolytes, liver enzymes, 
calcium, phosphate and total cholesterol were done on an 
automated Technicon DAX analyser (Bayer). HDL was 
analysed using a heparin-manganese precipitation method 
(Merck reagent kits) and low-density lipoprotein (LDL) using a 
differential precipitation method (Merck). Triglycerides were 
analysed using a Synchron CX system (Beckman instruments). 
A Synchron CX Delta system, using an oxygen rate method 
employing a Beckman Oxygen electrode, was used for plasma 
-------------------------------------------------------------------------------------------------
glucose determination. A radio-immunoassay (RIA) 
(Pharmacia) was used for serum insulin (cross reactivity with 
pro-insulin 41 %). 
Between-group comparisons were done using Mann-
Whitney U or Kruskal-Wallis tests. In order to normalise their 
distributions for regression purposes some variables were log 
transformed (HDL cholesterol, triglycerides, glucose, insulin). 
Multivariate regression analysis was done to determine the 
age-adjusted regression coefficients between the different 
measures of obesity and the studied metabolic factors. Because 
it is not possible to compare the magnitude of different 
regression coefficients directly, regression coefficients can be 
normalised by the ratio of the standard deviation (SD) of the 
regressor to the SD of the dependent variable. These 
coefficients are unitless and their magnitude can be compared. 
The fit of the model was assessed using adjusted r' and the 
Akaike information criterion (obtained from best subset 
regression using age and the specified obesity measure in the 
bivariate model). 18 
P-values < 0.05 were regarded as being statistically 
significant. Analyses were done on Statistica software. 
RESULTS 
The baseline characteristics of the women are given in Table I. 
Fourteen women (11.3%) were on oestrogen replacement 
therapy (10 of them on combined oestrogen and 
medroxyprogesterone). The prevalence of the different 
components of the metabolic syndrome7 was: 66.1% had BMis 
> 30 kg/m2, 25.8% had WHRs > 0.9, 13.2% had impaired 
Table I. Clinical characteristics of 124 black hypertensive women 
(mean (SD)) 
Age (yrs) 56.9 11.0 
Systolic blood pressure (mmHg) 149.5 22.7 
Diastolic blood pressure (mmHg) 90.7 11.0 
Body mass index (kg/m') 34.1 8.1 
Waist-hip ratio 0.81 0.10 
Uric acid (mmol/1) 0.36 0.09 
Creatinine (}lmol/1) 88.9 17.1 
Total cholesterol (mmol/1) 5.3 1.1 
LDL cholesterol (mmol/1) 3.6 1.1 
HDL cholesterol (mmol/1) 1.17 0.32 
Triglycerides (mmol/1) 1.49 0.67 
Glucose (mmol/1) 5.7 1.6 
Insulin (}lU /ml) 11.6 5.3 
Median number of anti-
hypertensive drugs 2.0 Range: 1-4 
On ACE inhibitors (%) 39.5 
On diuretics(%) 97.6 
Impaired fasting glucose(%) 13.0 
Diabetes mellitus (%) 9.1 
fasting glycaemia (IFG) (fasting plasma glucose 
6.1 -7.0 mmol/1), 9.1% had diabetes (fasting plasma glucose 
~ 7.0 mmol/1), and 38.5% dyslipidaemia (fasting plasma 
triglycerides ~ 1.7 mmol/1 and/ or HDL < 1.0 mmol/1). In 13% 
of the women none of the components was present, whereas 
42% had two or more components. 
Angiotensin-converting enzyme (ACE) inhibitors were used 
by 39.5% of the women in our study, all but one in combination 
with low-dose thiazide diuretics. Subjects on ACE inhibitors 
had higher LDL levels (3.92 mmol/1, SD 1.21) than those 
without (3.36 mmol/1, SD 0.92, P < 0.01). They also had lower 
HDLlevels (1.10 mmol/1, SD 0.28 versus 1.22 mmol/1, SD 0.33, 
P < 0.05). There were no statistically significant differences in 
BMI, WHR and insulin levels. 
There was no statistically significant difference between 
oestrogen users and non-users with regard to BP, BMI, waist 
measurement, uric acid, lipid measurements, glucose or insulin 
levels. 
The age-adjusted and standardised regression coefficients for 
waist circumference, WHR and BMI and metabolic risk factors 
are given in Table II. HDL, triglycerides, uric acid and insulin 
all showed a significant relationship with waist circumference. 
The significance of none of these was altered if subjects with 
diabetes were excluded from the analysis. The association with 
BMI and WHR were less marked. Additional adjustment for 
the use of ACE inhibitors did not change the results either. 
Diuretic use is associated with changes in lipids and uric acid. 19 
However, for diuretic dose to be a confounder it has to be 
associated with both features of the metabolic syndrome as 
well as measures of obesity."' We found marginal age-adjusted 
differences in total cholesterol (P"' 0.09) and LDL (P = 0.06), 
but waist (P = 0.99), WHR (P = 0.45) and BMI (P = 0.83) did not 
differ significantly between different dosage groups. As 
expected, adjusting for diuretic dose in the regression analyses 
did not change the findings in a meaningful way (data not 
shown). 
Waist circumference was the only significant determinant of 
HDL, whereas WHR was a better predictor of triglycerides 
than waist circumference (larger standardised regression 
coefficient). Waist circumference but not WHR was related to 
uric acid. All three measures of obesity were related to insulin, 
with waist circumference having the largest standardised 
coefficent. There was, however, no statistically significant 
difference between the coefficients of waist circumference and 
BMI for uric acid and insulin. The adjusted r' values as well as 
the Akaike information criterion concurred with the 
standardised regression coefficients regarding the best 
coefficients for predicting components of the metabolic 
syndrome. 
We had no data concerning menopausal status and 
arbitrarily divided the women into those younger than 
50 years and those 50 years and older. Adjusting for ACE 
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Table II. Age-adjusted associations between obesity measures and metabolic factors (coefficients (SEM) 
Regression coefficients 
Waist WHR BMI 
Systolic blood pressure 
-0.146 20.009 -0.202 
(0.178) (19.217) (0.245) 
Diastolic blood. pressure 
-0.024 8.660 0.012 
(0.087) (9.387) (0.120) 
Total cholesterol 
-0.002 -0.294 -0.001 
(0.008) (0.900) (0.011) 
LDL cholesterol 
0.004 0.397 -0.0003 
(0.009) (0.928) (0.012) 
Log HDL cholesterol 
-,0.006* -0.373 -0.003 
(0.002) (0.220) (0.003) 
Log triglycerides 
0.007§ 0.9731: 0.001 
(0.003) (0.342) (0.004) 
Log glucose 
0.003 0.294 0.002 
(0.002) (0.165) (0.002) 
Uric acid 
o.oo2n 0.127 o.oo2* 
(0.001) (0.075) (0.001) 
L0g insulin 
0.012* 0.833 0.009+ 
(0.003) (0.324) (0.004) 
* See method section fOr det~ils. 
t For model with largest standardised coefficient. 
lP<O.Ol 
§ p <0.05. 
11 p < 0.001. 
inhibitor use, but not for age, neither waist circumference nor 
WHR were related to HDL or triglyceridesin those< 50 years, 
but both were in the older age group. For log HDL the 
coefficient of waist was -0.008 (standard error of the mean 
(SEM) 0.002, P < 0.01) and of WHR -0.714 (0.342, P < 0.05); for 
log triglycerides the coefficient of waist was 0.008 (0.004, 
P < 0.05) and of WHR 1.538 (0.505, P < 0.01). For uric acid and 
insulin this discrepancy between the pre- and postmenopausal 
women was not found. 
The associations between BMI, and uric acid and insulin 
were no longer statistically significant if the women with 
diabetes were excluded from the analyses. However, the 
IIIiJ associations between WHR, and glucose and uric acid became 
statistically significant (regression coefficients 0.260 (SEM 0.096, 
P < 0.01) and 0.149 (0.074, P < 0.05), respectively). 
DISCUSSION 
Our study shows that in treated black South African 
hypertensive women there is an association between measures 
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Standardised coefficients* 
Waist WHR BMI Adjusted rt 
-0.072 0.091 -0.072 0.05 
(0.088) (0.088) (0.088) 
-0.024 0.081 0.009 0.04 
(0.088) (0.088) (0.088) 
-0.018 -0.029 -0.005 0.04 
(0.088) (0.088) (0.088) 
0.042 0.038 -0.002 0.01 
(0.090) (0.090) (0.090) 
-0.246 -0.151 -0.098 0.06 
(0.087) (0.089) (0.090) 
0.208 0.250 0.022 0.07 
(0.089) (0.088) (0.091) 
0.171 0.159 0.095 0.05 
(0.089) (0.089) (0.090) 
0.316 0.150 0.201 0.13 
(0.084) (0.088) (0.087) 
0.342 0.229 0.184 0.11 
(0.086) (0.089) (0.090) 
of central obesity and components of the metabolic syndrome. 
Waist circumference best predicted insulin, uric acid and 
glucose whereas WHR best predicted triglycerides (based on 
the standardised regression coefficients). The association 
between waist circumference and HDL cholesterol as well as 
triglycerides was only found in women older than 50 years. 
The selected women do not represent a true random sample 
of hypertensive women from the community as they were 
selected from the outpatient clinic. Women unable to 
communicate in English were excluded. This may have biased 
our sample towards women with a more westernised lifestyle 
in whom obesity may be more pronounced. The community of 
Mamelodi, however, is relatively homogeneous socio-
economically. Also, as westernisation of lifestyle (including 
diet) is increasing in South African black communities, this 
group is of particular interest. 
Age and menopause effect changes on cardiovascular 
parameters, as is also shown in our data. In a review of the 
literature Spencer et al.21 found that increased insulin resistance 
and decreased insulin secretion were found at or after the 
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menopause. In our relatively small study the effect of insulin 
was more marked in the pre-menopausal group. 
Prospective studies have reported clear associations between 
body fat distribution and the incidence of type 2 DM and 
cardiovascular disease."·" A recent study examining the 
differential aspects of BMI on diabetes risk among black and 
white Americans found that there is a higher risk for blacks 
than whites at a low BMI, and an equivalent risk for both 
groups at a high BMI. The authors conclude that a lower 
degree of visceral adiposity among blacks at higher BMI or a 
greater impact of visceral adiposity among blacks at lower 
BMI may help to explain the interaction of race and BMI on 
diabetes risk 24 
The effect of visceral fat may not be the same in African 
Americans versus Africans. Some authors suggest that BMI, a 
general indicator of obesity, is a better correlate of BP than the 
WHR among African Americans,25 whereas others found that 
waist circumference was positively correlated with BP in 
Nigerians, Jamaicans and African Americans.26 
Euglycaemic clamp studies in South African blacks have 
shown that hypertension per se is associated with insulin 
resistance and relative hyperinsulinaemia.27 In a study of 
elderly Nigerians, insulin resistance was found in 35%. In 
regression analysis this was linked to BP and body mass, 
particularly in women. Twenty per cent of subjects had more 
than four risk factors for CHD in spite of a low reported 
incidence of CHD.28 
The question whether insulin resistance or visceral fat is the 
underlying disturbance in the metabolic syndrome has not yet 
been resolved. Moreover, most studies on this topic have been 
performed in Caucasian populations. It is not evident if these 
results can be applied to black subjects. 
Concomitant antihypertensive therapy may influence several 
metabolic factors such as lipids and insulin. Joffe et al." have 
shown that thiazide diuretics incurred greater changes in the 
lipid profile of black subjects than did DM. These authors 
suggested that the metabolic syndrome does not apply to the 
South African black population as obesity and type 2 DM 
commonly occur with minimal elevation of serum lipids and a 
low prevalence of ischaemic heart disease. Their study 
supported the hypothesis that thiazide-treated hypertension 
may have greater atherogenic potential than diabetes. Diuretic 
use is often regarded as a confounder in the study of 
relationships with cardiovascular risk factors. The associations 
we describe, however, cannot be confounded by diuretic use as 
virtually all the subjects were on diuretic-based therapy 
(independent of their obesity measures). 
Our study of thiazide-treated hypertensives shows a very 
strong association between measures of central adiposity and 
measures of insulin, glucose and lipids. This suggests that 
apart from the effect of thiazide diuretics, clustering of 
metabolic risk factors does occur in these hypertensives and is 
related to central adiposity, 
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